March 1 (Reuters) - Eli Lilly and Co (LLY.N), opens new tab on Wednesday said it will cut list prices by 70% for its most commonly prescribed insulin products, Humalog and Humulin, beginning from the ...

Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay to fill prescriptions. The moves announced Wednesday promise critical ...

Eli Lilly is cutting the price of its insulin products, announcing Wednesday a plan to reduce the cost of its branded drug Humalog and set a $25-per-vial cap on a non-branded Humalog alternative. The ...

HARRISBURG, Pa. — Eli Lilly, one of the nation’s biggest manufacturers of insulin, announced it will reduce the list price of some of its insulins and cap out-of-pocket insulin costs to $35 a month.